Skip to main content
Fig. 3 | Epigenetics & Chromatin

Fig. 3

From: De novo methylation of histone H3K23 by the methyltransferases EHMT1/GLP and EHMT2/G9a

Fig. 3

Pharmacologic inhibition of EHMT1/GLP and EHMT2/G9a decreases H3K9 and H3K23 methylation in vivo. 50B11 (rat) or HEK203 (human) cells were treated with either 10 uM UNC0642 or DMSO for 5 days. At the conclusion of the treatment, the cells were harvested, and extracts were blotted for various histone H3K9 or H3K23 methylation states to evaluate changes in these methylation states in vivo

Back to article page